Search for a Writer:
Calculated Writer Scores
- Frequency of opinion markers: Not set
- Sentiment markers: Not set
- What is this?
Community Writer Scores
Coverage
Words Associated with SHIRLEY S. WANG
Most Frequently Mentioned Topics
Sources They're Writing For (last 60 days)
Writer Feed Widget
Grab this free widget and get the latest news for this writer. You can post it on your web page or blog, or add it to your desktop. Click on the "get & share" button at the bottom.
Articles Written by: SHIRLEY S. WANG
Wyeth disclosed some interesting tidbits during its earnings call this morning:
1. The company is facing a delay enrolling patients in the European trial of its key experimental Alzheimer’s treatment, bapineuzumab. After phase II study results raised ...
Robert Cialdini, a noted psychologist who studies persuasion, stopped by to talk with the Health Blog recently. We asked him how people could be persuaded to make better health choices.
The author of a new book “INFLUENCE: Science and Practice,” ...
WSJ’s blog on health and the business of health.
Johnson & Johnson has named Sheri McCoy, the new head of its pharmaceutical unit. McCoy, now in charge of surgical products at J&J, will take over for Christine Poon, who’s retiring next March.
McCoy, ...
WSJ’s blog on health and the business of health.
The grim economy and quaking stock market are driving masters of the financial universe to seek professional help for anxiety, and eroding sense of identity or tips on how to deal with angry clients, ...
RSS -- subscribe to updated headlines to read from anywhere on the Web. For more about RSS, click here.
WSJ's Health Blog offers news and analysis on health and the business of health. The lead writer is Jacob Goldstein. He came to The Wall Street ...
WSJ’s blog on health and the business of health.
Stem cells’ value derives from their ability to change into different types of cells in various parts of the body and thus may be a way to cure some diseases and repair damaged organs. Scientists are ...
WSJ’s blog on health and the business of health.
Regulation is becoming all the rage these days, what with the second-guessing of the financial markets. Online pharmacies that sell controlled substances like pain pills to consumers are about to get ...
WSJ’s blog on health and the business of health.
Even as Pfizer is bailing out of drug research for heart disease, the company’s late-stage pipeline has increased to 25 projects from 16 in the past six months.
The new figures come from Pfizer’s ...
WSJ’s blog on health and the business of health.
J&J is still awaiting approval from the FDA to sell ustekinumab, the company’s experimental treatment for psoriasis. In the meantime, the results from the first head-to-head study of two biotech drugs ...
Fine wine flowed last night in New York for Marc Feldmann and Ravinder Maini, scientists from the Kennedy Institute of Rheumatology at Imperial College London. The pair was feted by Johnson & Johnson for work that paved the way for drugs called TNF ...
